Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20,695 | 9 | 69.8% |
| Food and Beverage | $5,323 | 244 | 17.9% |
| Travel and Lodging | $3,642 | 17 | 12.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $13,503 | 78 | $0 (2024) |
| Boston Scientific Corporation | $7,791 | 30 | $0 (2024) |
| Gilead Sciences, Inc. | $4,311 | 18 | $0 (2018) |
| Medical Device Business Services, Inc. | $1,462 | 11 | $0 (2019) |
| Edwards Lifesciences Corporation | $502.72 | 17 | $0 (2024) |
| Cardiovascular Systems Inc. | $357.03 | 16 | $0 (2020) |
| ABIOMED | $308.60 | 9 | $0 (2021) |
| PFIZER INC. | $248.22 | 19 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $167.82 | 14 | $0 (2023) |
| Merck Sharp & Dohme LLC | $127.50 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $729.78 | 49 | Boston Scientific Corporation ($276.60) |
| 2023 | $476.21 | 29 | Novartis Pharmaceuticals Corporation ($134.16) |
| 2022 | $566.37 | 33 | Novartis Pharmaceuticals Corporation ($202.04) |
| 2021 | $419.57 | 21 | ABIOMED ($196.91) |
| 2020 | $211.87 | 9 | ABIOMED ($100.00) |
| 2019 | $2,350 | 34 | Medical Device Business Services, Inc. ($1,462) |
| 2018 | $7,801 | 52 | BOSTON SCIENTIFIC CORPORATION ($6,776) |
| 2017 | $17,104 | 43 | Novartis Pharmaceuticals Corporation ($12,898) |
All Payment Transactions
270 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/21/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Genetic Disease | ||||||
| 11/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $4.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $4.89 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/21/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $27.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/02/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Iron Deficiency Anemia | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $5.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $0.89 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/26/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $10.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/13/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $22.37 | General |
| 08/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $5.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/05/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $0.89 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/31/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $22.65 | General |
| 07/30/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $5.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $0.89 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/18/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $23.41 | General |
| Category: Cardiovascular | ||||||
| 07/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $4.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $0.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/25/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $0.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/21/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Not Applicable | ||||||
| 06/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $4.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $0.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 3,206 | 3,933 | $1.1M | $408,068 |
| 2022 | 28 | 3,146 | 3,760 | $1.0M | $391,579 |
| 2021 | 33 | 2,972 | 3,621 | $961,770 | $379,166 |
| 2020 | 29 | 2,067 | 2,384 | $701,640 | $275,293 |
All Medicare Procedures & Services
131 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 920 | 929 | $317,115 | $113,040 | 35.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 153 | 153 | $125,474 | $51,336 | 40.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 338 | 368 | $64,400 | $33,257 | 51.6% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 157 | 628 | $40,650 | $27,276 | 67.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 170 | 170 | $80,320 | $22,005 | 27.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 120 | 122 | $39,040 | $16,490 | 42.2% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 89 | 90 | $53,100 | $15,413 | 29.0% |
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2023 | 11 | 11 | $38,500 | $13,923 | 36.2% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 152 | 304 | $17,328 | $13,582 | 78.4% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 29 | 33 | $33,000 | $13,501 | 40.9% |
| 33340 | Repair of left upper heart chamber with implant with review by radiologist | Facility | 2023 | 20 | 20 | $30,000 | $11,896 | 39.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 179 | 181 | $25,340 | $9,596 | 37.9% |
| 33361 | Replacement of aortic valve through the skin and femoral artery | Facility | 2023 | 16 | 16 | $29,120 | $9,076 | 31.2% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 166 | 166 | $62,250 | $7,995 | 12.8% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 11 | 22 | $9,350 | $7,502 | 80.2% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 40 | 40 | $14,685 | $6,609 | 45.0% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 18 | 18 | $13,320 | $4,951 | 37.2% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 36 | 36 | $11,340 | $4,538 | 40.0% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 46 | 46 | $13,800 | $4,217 | 30.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $8,525 | $3,826 | 44.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 39 | 57 | $6,270 | $3,532 | 56.3% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 16 | 16 | $8,400 | $2,896 | 34.5% |
| 76706 | Ultrasound scan of abdominal aorta | Office | 2023 | 20 | 20 | $3,000 | $1,984 | 66.1% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 14 | 14 | $4,620 | $1,737 | 37.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 28 | $3,080 | $1,730 | 56.2% |
About Dr. Michael Sassower, MD
Dr. Michael Sassower, MD is a Interventional Cardiology healthcare provider based in Utica, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710945159.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Sassower, MD has received a total of $29,660 in payments from pharmaceutical and medical device companies, with $729.78 received in 2024. These payments were reported across 270 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($20,695).
As a Medicare-enrolled provider, Sassower has provided services to 11,391 Medicare beneficiaries, totaling 13,698 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 131 distinct procedure/service records.
Practice Information
- Specialty Interventional Cardiology
- Location Utica, NY
- Active Since 05/03/2006
- Last Updated 07/13/2012
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1710945159
Products in Payments
- ENTRESTO (Drug) $13,272
- GENERAL VASCULAR ACCESS (Device) $4,651
- Ranexa (Drug) $4,220
- WATCHMAN (Device) $1,567
- Carto 3 System (Device) $1,462
- THERAPIES (Device) $715.50
- Impella (Device) $308.60
- WATCHMAN Access System (Device) $288.36
- LEQVIO (Drug) $230.81
- GENERAL STENTS (Device) $219.95
- Peripheral Orbital Atherectomy System (Device) $185.41
- Coronary Orbital Atherectomy System (Device) $171.62
- ELIQUIS (Drug) $171.34
- LifeVest (Device) $167.82
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $162.54
- VERQUVO (Drug) $127.50
- PRADAXA (Drug) $121.87
- GENERAL STENTS (Device) $119.40
- XARELTO (Drug) $108.43
- Cook Medical Zilver PTX (Device) $84.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Utica
Hugh Macisaac, Md, MD
Interventional Cardiology — Payments: $10,951
Prabhat Varma, Md, MD
Interventional Cardiology — Payments: $7,372
Michael Kelberman, Md, MD
Interventional Cardiology — Payments: $6,526
Ashok Patel, Md, MD
Interventional Cardiology — Payments: $5,867
Rakesh Bhan, Md, MD
Interventional Cardiology — Payments: $3,879
Ramzi Nassif, Md, MD
Interventional Cardiology — Payments: $3,228